Currently predicting for Wed, 1 May 2024

Trading levels for ACAD

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 17.46 4.51 %
R2 17.21 2.98 %
R1 17.05 2.03 %
Current price: 16.71
Support S1 16.54 -1.03 %
S2 16.38 -1.98 %
S3 16.12 -3.51 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 19.98 19.57 %
R2 18.48 10.59 %
R1 16.82 0.658 %
Current price 16.71
Support S1 16.59 -0.718%
S2 16.31 -2.39%
S3 0 .

ACAD Predictions History

3 years ago
Marc-Antoine Robert predicted that ACAD for 2020-11-09 is going

Rank:

3 years ago
sander7100 yo bro predicted that ACAD for 2020-08-13 is going $40.04 (0.33%)

3 years ago
JS predicted that ACAD for 2020-08-13 is going $39.35 (-1.40%)

3 years ago
iHustle84 predicted that ACAD for 2020-08-13 is going $37.78 (-5.34%)

3 years ago
2poJeff predicted that ACAD for 2020-08-13 is going $39.40 (-1.15%)

4 years ago
Todor Lapkov predicted that ACAD for 2020-03-05 is going $45.10 (1.60%)

Rank:

4 years ago
JS predicted that ACAD for 2019-09-11 is going $36.84 (-10.99%)

4 years ago
GoldenNugget predicted that ACAD for 2019-05-07 is going $26.76 (-0.13%)

5 years ago
NameNotImportant predicted that ACAD for 2019-04-29 is going $25.58 (1.83%)

5 years ago
Thom predicted that ACAD for 2019-04-09 is going $28.00 (3.44%)

Rank:
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT